Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Clinical trial NCT01055847 · COMPLETED

Trial details

NCT number: NCT01055847
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis CF Lung Infection Pseudomonas Aeruginosa

Start date: 2003-06-01
Primary completion: 2004-08-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.